This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Doorn, L. J.
Right arrow Articles by Quint, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Doorn, L. J.
Right arrow Articles by Quint, W.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, 07 1996, 1784-1787, Vol 34, No. 7
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Analysis of hepatitis C virus isolates by serotyping and genotyping

LJ van Doorn, B Kleter, I Pike and W Quint
Diagnostic Center SSDZ, Department of Molecular Biology, GA Delft, The Netherlands. L.J.van.Doorn@ddl.nl

Hepatitis C virus (HCV)-positive sera from 106 chronically infected patients which had previously been genotyped were characterized by serotyping. Genotypes were determined by a first-generation line probe assay (INNO-LiPA HCV) and by sequence analyses of the core, core-E1, and NS5B regions. HCV serotypes were determined by measuring type- specific antibodies to NS4-derived peptide antigens (Murex HCV serotyping 1-6 assay). Of 106 serum samples, serotype-specific antibodies were detected in 88 (sensitivity, 83.0%), and 77 (specificity, 87.5%) of these serotypeable samples revealed a corresponding serotype (total concordance, 72.6%). Eleven samples revealed discrepant results as follows. (i) Five serum samples in which only a single genotype was detected contained an additional serotype. (ii) In one sample with two genotypes only one serotype was detected. (iii) In five isolates the serotype (all serotype 1) was completely different from the genotype. Double infections, as determined by genotyping, were confirmed by serotyping in two of four cases. Of 11 serum samples from chronically infected hemodialysis patients, 7 (64%) were reactive in the serotyping assay. In conclusion, genotyping allows discrimination between (sub)types but requires the relatively complex reverse transcriptase PCR. The novel serotyping assay offers an alternative method to distinguish the major types of HCV, although the sensitivity of the assay may be limited by the immunocompetence of the infected host.


This article has been cited by other articles:

  • Gault, E., Soussan, P., Morice, Y., Sanders, L., Berrada, A., Rogers, B., Deny, P. (2003). Evaluation of a New Serotyping Assay for Detection of Anti-Hepatitis C Virus Type-Specific Antibodies in Serum Samples. J. Clin. Microbiol. 41: 2084-2087 [Abstract] [Full Text]  
  • Rodriguez-Lopez, M, Riezu-Boj, J., Ruiz, M, Berasain, C, Civeira, M., Prieto, J, Borras-Cuesta, F (1999). Immunogenicity of variable regions of hepatitis C virus proteins: selection and modification of peptide epitopes to assess hepatitis C virus genotypes by ELISA. J. Gen. Virol. 80: 727-738 [Abstract]  
  • Songsivilai, S., Kanistanon, D., Dharakul, T. (1998). A Serotyping Assay for Hepatitis C Virus in Southeast Asia. CVI 5: 737-739 [Abstract] [Full Text]  
  • Muir, P., Kammerer, U., Korn, K., Mulders, M. N., Poyry, T., Weissbrich, B., Kandolf, R., Cleator, G. M., van Loon, A. M. (1998). Molecular Typing of Enteroviruses: Current Status and Future Requirements. Clin. Microbiol. Rev. 11: 202-227 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»